secwatch / observer
8-K filed December 12, 2023, 6:59 PM ET ticker SIGY CIK 0001642159
leadership confidence high sentiment neutral materiality 0.50

Sigyn Therapeutics removes CFO Jeremy Ferrell, appoints Jerry DeCiccio as replacement

Sigyn Therapeutics, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeremy Ferrell

Chief Financial Officer
SIGY · Sigyn Therapeutics, Inc.
Effective
2023-12-12
Successor
Jerry DeCiccio
Filed
December 12, 2023, 6:59 PM ET
the Company removed Jeremy Ferrell from his position as CFO of the Company, effective immediately.
Appointed

Jerry DeCiccio

Chief Financial Officer
SIGY · Sigyn Therapeutics, Inc.
Effective
2023-12-12
Filed
December 12, 2023, 6:59 PM ET
The Company has appointed Jerry DeCiccio to serve as the Chief Financial Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jeremy Ferrell was removed as Chief Financial Officer at Sigyn Therapeutics, Inc..

Action
removed
Role
Chief Financial Officer
Exact text from the filing
the Company removed Jeremy Ferrell from his position as CFO of the Company, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Jerry DeCiccio was appointed as Chief Financial Officer at Sigyn Therapeutics, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
The Company has appointed Jerry DeCiccio to serve as the Chief Financial Officer of the Company, effective immediately.
View on SEC.gov

Sigyn Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-044529
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.